World Journal of Urology

, Volume 25, Issue 4, pp 351–359

Value of magnetic resonance imaging in prostate cancer diagnosis

  • Friedrich Aigner
  • Leo Pallwein
  • Alexandre Pelzer
  • Georg Schaefer
  • Georg Bartsch
  • Dieter zur Nedden
  • Ferdinand Frauscher
Topic Paper


MRI has shown its potential in prostate cancer (PCa) imaging. MRI is able to demonstrate zonal anatomy with excellent contrast resolution. Furthermore it can detect PCa dependent not only on tumor-size, histological grading, PSA levels, but also on technical equipment and reader’s experience. Non-palpable PCas in the inner and outer gland can be detected by this technique. Another potential is that MRI is helpful for tumor staging and treatment planning as well as response evaluation. Besides the morphological information, MRI can give functional information based on metabolic evaluation with proton magnetic resonance spectroscopy and of tumor angiogenesis based on dynamic contrast-material enhanced MRI and diffusion-weighted imaging. In addition MRI can be used for targeted prostate biopsies; however, the clinical practicability is questionable. Furthermore many data about the value of MRI for PCa diagnosis are based on transrectal ultrasound (TRUS) biopsy findings. Since there is lack of accuracy in fusing MRI images with TRUS images these limit the results of MRI for cancer diagnosis. However, in the future MRI may play an additional role in planning and monitoring minimally invasive PCa therapies. Although, MRI of the prostate seems to be useful, nevertheless this method remains expensive and lacks availability regarding the oncoming requirements.


Magnetic resonance imaging Magnetic resonance spectroscopy imaging Prostate cancer Staging Prostate cancer Grading 


  1. 1.
    Pallwein L, Mitterberger M, Struve P et al (2007) Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. Eur Radiol [Mar 7; Epub ahead of print]Google Scholar
  2. 2.
    Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ (1997) Optimization of prostate biopsy strategy using computer based analysis. J Urol 158:2168–2175PubMedCrossRefGoogle Scholar
  3. 3.
    Motulsky H (1995) Intuitive biostatistics. Oxford University Press, New York, p 129Google Scholar
  4. 4.
    Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566PubMedCrossRefGoogle Scholar
  5. 5.
    Byar DP, Mostofi FK (1972) Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 30(1):5–13PubMedCrossRefGoogle Scholar
  6. 6.
    Choi YJ, Kim JK, Kim N et al (2007) Functional MR imaging of prostate cancer. RadioGraphics 27:63–75PubMedGoogle Scholar
  7. 7.
    Beyersdorff D, Winkel A, Hamm B et al (2005) MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 234(2):576–581. Epub 2004 Dec 22PubMedCrossRefGoogle Scholar
  8. 8.
    Brown TR, Kincaid BM, Ugurbil K (1982) NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 79:3523–3526PubMedCrossRefGoogle Scholar
  9. 9.
    Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB (1997) Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 38:311–321PubMedCrossRefGoogle Scholar
  10. 10.
    Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24:S167–S180PubMedCrossRefGoogle Scholar
  11. 11.
    Futterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils : local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17(4):1055–1065PubMedCrossRefGoogle Scholar
  12. 12.
    Kurhanewicz J, Vigneron DB, Hricak H, Navayan P, Carroll P, Nelson SJ (1996) Three-dimensional 1H MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm3) spatial resolution. Radiology 198:795–805PubMedGoogle Scholar
  13. 13.
    Schnall MD, Pollack HM (1990) Magnetic resonance imaging of the prostate. Urol Radiol 12:109–114PubMedCrossRefGoogle Scholar
  14. 14.
    Ikonen S, Kivisaari L, Vehmas T et al (2001) Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol 42:70–73PubMedCrossRefGoogle Scholar
  15. 15.
    White S, Hricak H, Forstner R et al (1995) Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385–390PubMedGoogle Scholar
  16. 16.
    Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302PubMedGoogle Scholar
  17. 17.
    Bartolozzi C, Menchi I, Lencioni R et al (1996) Local staging of prostate carcinoma with endorectal coil MRI: correlation with whole-mount radical prostatectomy specimens. Eur Radiol 6(3):339–345PubMedCrossRefGoogle Scholar
  18. 18.
    Cornud F, Flam T Chauvenic L et al (2002) Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 224(1):203–210PubMedCrossRefGoogle Scholar
  19. 19.
    Ikonen S, Karkkainen P, Kivisaari L et al (1998) Magnetic resonance imaging of clinically localized prostatic cancer. J Urol 159(3):915–919PubMedCrossRefGoogle Scholar
  20. 20.
    Ikonen S, Karkkainen P, Kivisaari L et al (2001) Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences. Eur Radiol 11(2):236–241PubMedCrossRefGoogle Scholar
  21. 21.
    May F, Treumann T, Dettmar P et al (2001) Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 87(1):66–69PubMedCrossRefGoogle Scholar
  22. 22.
    Perrotti M, Kaufman RP, Jennings TA et al (1996) Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol 156(1):106–109PubMedCrossRefGoogle Scholar
  23. 23.
    Presti JC, Hricak H, Narayan PA et al (1996) Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol 166(1):103–108PubMedGoogle Scholar
  24. 24.
    Rorvik J, Halvorsen OJ, Albrektsen G et al (1999) MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 9(1):29–34PubMedCrossRefGoogle Scholar
  25. 25.
    Yu KK, Hricak H, Alagappan R et al (1997) Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 202(3):697–702PubMedGoogle Scholar
  26. 26.
    Mullerad M, Hricak H, Kuroiwa K et al (2005) Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174(6):2158–2163PubMedCrossRefGoogle Scholar
  27. 27.
    Akin O, Sala E, Moskowitz CS et al (2006) Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239(3):784–792PubMedCrossRefGoogle Scholar
  28. 28.
    Pelzer AE, Bektic J, Berger AP et al (2005) Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project. Eur Urol 48(6):916–921 discussion 921PubMedCrossRefGoogle Scholar
  29. 29.
    Hricak H (2005) MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 78(Spec No 2):S103–S111PubMedCrossRefGoogle Scholar
  30. 30.
    Males RG, Vigneron DB, Star-Lack J et al (2000) Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med 43:17–22PubMedCrossRefGoogle Scholar
  31. 31.
    Scheidler J, Hricak H, Vigneron DB et al (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study. Radiology 213:473–480PubMedGoogle Scholar
  32. 32.
    Zakian KL, Eberhardt S, Hricak H et al (2003) Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging—initial results. Radiology 229:241–247PubMedCrossRefGoogle Scholar
  33. 33.
    Prando A, Kurhanewicz J, Borges AP et al (2005) Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236(3):903–910PubMedCrossRefGoogle Scholar
  34. 34.
    Coakley FV, Kurhanewicz J, Lu Y et al (2002) Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223(1):91–97PubMedCrossRefGoogle Scholar
  35. 35.
    Qayyum A, Coakley FV, Lu Y et al (2002) Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223(1):91–97CrossRefGoogle Scholar
  36. 36.
    Brassell SA, Krueger WR, Choi JH, Taylor JA 3rd (2004) Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage. World J Urol 22(4):289–292PubMedCrossRefGoogle Scholar
  37. 37.
    Beer M, Schmidt H, Riedl R (1989) The clinical value of preoperative staging of bladder and prostatic cancers with nuclear magnetic resonance and computerized tomography. Urologe A 28(2):65–69PubMedGoogle Scholar
  38. 38.
    Bezzi M, Kressel HY, Allen KS et al (1988) Prostatic carcinoma: staging with MR imaging at 1.5 T. Radiology 169(2):339–346PubMedGoogle Scholar
  39. 39.
    Jager GJ, Barentsz JO, Oosterhof GO et al (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 167(6):1503–1507PubMedGoogle Scholar
  40. 40.
    Kier R, Wain S, Troiano R (1993) Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma. AJR Am J Roentgenol 161(3):601–606PubMedGoogle Scholar
  41. 41.
    Nicolas V, Beese M, Keulers A et al (1994) MR tomography in prostatic carcinoma: comparison of conventional and endorectal MRT. Rofo 161(4):319–326PubMedGoogle Scholar
  42. 42.
    Tuzel E, Sevinc M, Obuz F et al (1998) Is magnetic resonance imaging necessary in the staging of prostate cancer? Urol Int 61:227–231PubMedCrossRefGoogle Scholar
  43. 43.
    Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25):2491–9 Erratum in: N Engl J Med. 2003;349(10):1010PubMedCrossRefGoogle Scholar
  44. 44.
    Zakian KL, Sircar K, Hricak H et al (2005) Correlation of proton MR spectrosocpic imaging with gleason score grade based on step-section pathology after radical prostatectomy. Radiology 234:804–814PubMedCrossRefGoogle Scholar
  45. 45.
    Stamey TA, McNeal JE, Freiha FS, Redwine E (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139(6):1235–1241PubMedGoogle Scholar
  46. 46.
    Bostwick DG, Graham SD Jr, Napalkov P et al (1993) Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41(5):403–411PubMedCrossRefGoogle Scholar
  47. 47.
    McNeal JE, Villers AA, Redwine EA et al (1990) Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol 14(3):240–247PubMedCrossRefGoogle Scholar
  48. 48.
    Yu KK, Scheidler J, Hricak H et al (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481–488PubMedGoogle Scholar
  49. 49.
    Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardino PT (2004) Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 232:140–146PubMedCrossRefGoogle Scholar
  50. 50.
    Latchamsetty KC, Borden LS Jr, Porter CR et al (2007) Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve? Can J Urol 14:3429–3434PubMedGoogle Scholar
  51. 51.
    Choyke PL (2005) Contrast agents for imaging tumor angiogenesis: is bigger better? Radiology 235(1):1–2PubMedCrossRefGoogle Scholar
  52. 52.
    Buckley DL, Roberts C, Parker GJ et al (2004) Prostate cancer: evaluation of vascular characteristics with dynamic contrast enhanced T1-weighted MR imaging—initial experience. Radiology 233:709–715PubMedCrossRefGoogle Scholar
  53. 53.
    Brix G, Semmler W, Port R et al (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MRI. J Comput Assist Tomogr 15:621–628PubMedCrossRefGoogle Scholar
  54. 54.
    Hofmann U, Brix G, Knopp MV et al (1995) Pharmacokinetic mapping of the breast: a new method for dynamic MR-mammography. Magn Reson Med 33:506–514CrossRefGoogle Scholar
  55. 55.
    Hawighorst H, Knopp MV, Debus J et al (1998) Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imaging 8:783–788PubMedCrossRefGoogle Scholar
  56. 56.
    Port RE, Knopp MV, Hoffmann U et al (1999) Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging 10:233–241PubMedCrossRefGoogle Scholar
  57. 57.
    Engelbrecht MR, Huisman HJ, Laheij RJet al (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229(1):248–254PubMedCrossRefGoogle Scholar
  58. 58.
    Kim JK, Hong SS, Choi YJ et al (2005) Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging 22:639–646PubMedCrossRefGoogle Scholar
  59. 59.
    Tien RD, Felsberg GJ, Friedman H et al (1994) MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162(3):671–677PubMedGoogle Scholar
  60. 60.
    Eis M, Els T, Hoehn-Berlage M (1995) High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat. Magn Reson Med 34(6):835–844PubMedCrossRefGoogle Scholar
  61. 61.
    Eis M, Els T, Hoehn-Berlage M, Hossmann KA (1994) Quantitative diffusion MR imaging of cerebral tumor and edema. Acta Neurochir Suppl (Wien) 60:344–346Google Scholar
  62. 62.
    Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9(1):53–60PubMedCrossRefGoogle Scholar
  63. 63.
    Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 22(1):60–64PubMedGoogle Scholar
  64. 64.
    Shimofusa R, Fujimoto H, Akamata H et al (2005) Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 29(2):149–153PubMedCrossRefGoogle Scholar
  65. 65.
    Anastasiadis AG, Lichy MP, Nagele U et al (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50:738–748PubMedCrossRefGoogle Scholar
  66. 66.
    Zangos S, Eichler K, Engelmann K et al (2005) MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results. Eur Radiol 15:174–182PubMedCrossRefGoogle Scholar
  67. 67.
    Hricak H, Wang L, Wei DC et al (2004) The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 100:2655–2663PubMedCrossRefGoogle Scholar
  68. 68.
    Sella T, Schwartz LH, Swindle PW et al (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231(2):379–385PubMedCrossRefGoogle Scholar
  69. 69.
    Silverman JM, Krebs TL (1997) MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol 168(2):379–385PubMedGoogle Scholar
  70. 70.
    D’Amico AV, Whittington R, Malkowicz B et al (2000) Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 164:759–763PubMedCrossRefGoogle Scholar
  71. 71.
    Wefer AE, Hricak H, Vigneron DB et al (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400–404PubMedCrossRefGoogle Scholar
  72. 72.
    Heuck A, Scheidler J, Sommer B, Graser A, Muller-Lisse UG, Massmann J (2003) MR imaging of prostate cancer. Radiologe 43:464–473PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Friedrich Aigner
    • 1
  • Leo Pallwein
    • 1
  • Alexandre Pelzer
    • 2
  • Georg Schaefer
    • 3
  • Georg Bartsch
    • 2
  • Dieter zur Nedden
    • 1
  • Ferdinand Frauscher
    • 1
  1. 1.Departments of Radiology II/UroradiologyMedical University InnsbruckInnsbruckAustria
  2. 2.Department of UrologyMedical University InnsbruckInnsbruckAustria
  3. 3.Department of PathologyMedical University InnsbruckInnsbruckAustria

Personalised recommendations